Eligibility criteria
Condition
Rheumatoid Arthritis
Sex
Females and Males
Age
20-75 years
Inclusion criteria
Show details
- Presence of >6 swollen joints and >6 tender joints
- Inadequate response to at least one disease modifying anti-rheumatic drug (DMARD)
- Have not been treated with a DMARD for at least 4 weeks prior to the baseline visit
Exclusion criteria
Show details
- Previous treatment with etanercept, antibody to TNF?, or other TNF? inhibitors
- Received investigational drugs within 6 months of the baseline visit
- Received intra-articular hyaluronic acid injections within 4 weeks of the baseline
visit